An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis - Wikidata - wikimedia - TriplyDB

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis

http://www.wikidata.org/entity/Q34492775

about

A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model Delivery of large heterologous polypeptides across the cytoplasmic membrane of antigen-presenting cells by the Bordetella RTX hemolysin moiety lacking the adenylyl cyclase domain.Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis.rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity.CD4 and CD8 T-cell responses to mycobacterial antigens in African children Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques.Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy.The Secreted Protein Rv1860 of Mycobacterium tuberculosis Stimulates Human Polyfunctional CD8+ T Cells Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis Tuberculosis: vaccines in the pipeline.T-cell mRNA expression in response to Mycobacterium bovis BCG vaccination and Mycobacterium bovis infection of white-tailed deer.Activation of the hypothalamic-pituitary-adrenal (HPA) axis contributes to the immunosuppression of mice infected with Angiostrongylus cantonensis.Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.Vaccination strategies to enhance local immunity and protection against Mycobacteriun tuberculosis.TB vaccines: current status and future perspectives.Antigen-Specific IFN-γ Responses Correlate with the Activity of M. tuberculosis Infection but Are Not Associated with the Severity of Tuberculosis Disease.Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines.Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination.Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells.Severe Tuberculosis in Humans Correlates Best with Neutrophil Abundance and Lymphocyte Deficiency and Does Not Correlate with Antigen-Specific CD4 T-Cell Response

P2860

Q24657992-7C5DBA47-4570-40DC-BA49-E6433194AE7D Q26774207-483097AA-9A38-4D4F-BAB1-0D8D21F722BF Q27315911-6839309A-58B0-438F-AF10-FFB52321C508 Q27349862-FE13D8BB-00AF-437D-B334-5334084D6099 Q28486372-C4D14597-4F2B-487A-A92A-6F2B9B33A7B1 Q28730427-906C997C-04EC-4412-BB29-32BE76EC0DAD Q30375962-55D34AFE-6980-441B-ACE2-582E13B5DFAD Q30425161-57FE1EBA-7E7A-4FD9-8D0A-6BE94922110C Q33355965-1A48DA16-B999-4846-9D98-0C3CFCC0F7CC Q33386020-6A1D1951-0DF0-4ED7-B521-84279889C3C9 Q33948002-5049E59C-BAFB-496E-8451-30E9CFACA6FB Q33954601-90D0BDEB-7A11-475E-A3B5-9CC00067B214 Q33988111-C3270FCB-3B09-4BBD-98AF-00C83D4846F2 Q34079170-E495FC92-CE5C-4FD3-ABB2-CE48D02B4AA1 Q34681015-D2A89F70-61CE-4D73-A92D-9E443D9A27BC Q35689094-2C1090C0-000B-4BD3-81BA-D240DF5BCD28 Q35927959-97EE2839-C644-4315-A039-E866C2FDDB46 Q36143523-D0DB8B55-F161-4315-BFB8-870D8335FB20 Q36303844-51CC87D3-4F63-4966-9532-C7154862B38C Q36305994-56DE53CD-F169-41FE-8601-28A1FEF5D357 Q36362277-C8703631-F92E-4A4B-8240-35B30C580E38 Q36419503-16BA5463-781E-40B9-ACFA-8BF8656ED17E Q36670729-738B9DD4-27CF-452F-856E-07C51B17E85F Q36764394-CD1F33DC-FBF3-4EF5-9F5F-819198A0F37A Q36899073-5D2E0104-DCB9-4792-B6E2-D047AF8ADEE0 Q36982831-7F97409A-EC7A-4E88-A3C4-5F539B64E35A Q37194790-EE4D872F-159B-423C-BD84-E76A330A5D6D Q37301890-515BBDC3-6CF7-45CC-B5BA-86A59C74DDEE Q37336682-43E7B8B7-8DB5-4E15-BABB-E4BDA0908AB4 Q37350429-0066330F-0D3F-4E4F-A332-325F0488D907 Q37401457-D63ED708-86E6-4CB4-8130-F2A2BBDC88C9 Q37435926-B870D857-F777-476B-9D67-AD82A90CAEEF Q37500859-A4CE3AD1-0FA1-42B6-A7E8-7F78F52C4D0B Q37843964-C9A03AEE-7523-4209-9131-0ECAFAE3B48E Q38236718-66275350-4794-4CC1-B95C-23F611550451 Q39456671-0A299EC3-B244-4956-8BB2-BB16775C2A58 Q39473407-37F9D84E-3FEA-43F1-89DC-1A2501BAC04C Q39707019-0FAED20C-E8C7-4DC6-BEE4-E1B082508B0E Q41021544-2E891630-021F-4562-A34D-411BE66C14F5 Q41487951-98958134-CDC7-41BD-931E-AB46DCDF728D

P2860

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis

http://www.wikidata.org/entity/Q34492775

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

An increase in antimycobacteri ...... rotection against tuberculosis

@ast

An increase in antimycobacteri ...... rotection against tuberculosis

@en

An increase in antimycobacteri ...... rotection against tuberculosis

@nl

type

label

An increase in antimycobacteri ...... rotection against tuberculosis

@ast

An increase in antimycobacteri ...... rotection against tuberculosis

@en

An increase in antimycobacteri ...... rotection against tuberculosis

@nl

prefLabel

An increase in antimycobacteri ...... rotection against tuberculosis

@ast

An increase in antimycobacteri ...... rotection against tuberculosis

@en

An increase in antimycobacteri ...... rotection against tuberculosis

@nl

P1433

Q34492775-04E414F2-F024-42E8-8A5C-6E07E9CB962D

P1476

Q34492775-C19EE48F-DEF2-4546-BF28-FB57724A2E96

P2093

Q34492775-71BD100A-93AA-4679-9D63-9A6F557CA023

Q34492775-7F8F91F6-E4A4-433D-ADB8-641843E30431

Q34492775-8233F999-D310-479B-B8A9-5FCEF4E4BF43

Q34492775-8515BDA1-F294-4E8E-A8FB-D62B6D3CF81C

Q34492775-9A04BA18-A1BF-4871-9198-50A58DFEA7C9

Q34492775-9FF1D783-9254-4DF9-B37A-74405696A7AB

Q34492775-A3B1FFE8-4C5A-43C1-8C76-B10CCB881F1D

Q34492775-CD775B48-E9EC-4F71-9098-ECD0EEF137C7

P2860

Q34492775-0DD95621-E5AF-4A8E-A3A8-BD330C7B5233

Q34492775-1257E3F1-44FC-4D0D-94ED-BB5E4807CFC1

Q34492775-1435E3EC-7754-48BF-97B9-C8ADF1111FF2

Q34492775-1D44D34E-7953-4EB4-9BD3-820A2D148504

Q34492775-1D7F27D7-01FE-4603-BBEF-03AAA0D50AF4

Q34492775-2244F32B-4E6E-4A2A-8C24-F43D114F18F0

Q34492775-23FAB39A-89AC-44C8-83A4-8B6031336474

Q34492775-27D9C827-9697-4F0E-9004-F30B9416881F

Q34492775-4673F01A-7279-4045-A7A8-56CD14A1C324

Q34492775-48242E97-B192-4353-8AE4-6AC478E6ADCE

P304

Q34492775-96F00849-A597-447C-BFC7-E077F3CA5272

P31

Q34492775-7CEA3FF6-D607-4DD7-8EB6-3E389233A715

P356

Q34492775-87E16771-3ED4-4BF2-B6F4-05EEC2BC1E5D

P407

Q34492775-801C6D1D-3C5C-44E0-93AA-01C11DBBED82

P433

Q34492775-26738DF3-FA83-44A5-9517-771A40C296CA

P478

Q34492775-52D89C16-A7C4-43B9-AD25-EC77F0C43469

P50

Q34492775-10994EB5-8D05-4905-9A8A-794C2C48044D

Q34492775-18648A4D-7119-4CCC-AFA4-AC983930B427

Q34492775-A3668D72-E88E-41A6-B219-3C8D8DA92238

P577

Q34492775-4AC40414-8A83-42F3-8AFE-E64396A742E6

P698

Q34492775-901E4115-6E4B-43D1-AEBF-15986A4B2CE6

P921

Q34492775-4388CE9E-AA60-430B-9507-AAEE0CC259DB

Q34492775-D8D13280-365B-4910-8582-51796457CD61

P932

Q34492775-D3743426-9E12-48B1-A41D-6F4CEC772A0D

P356

IAI.74.4.2128-2137.2006

P1433

Infection and Immunity

P1476

An increase in antimycobacteri ...... rotection against tuberculosis

@en

P2093

Claude Leclerc

http://www.w3.org/2001/XMLSchema#string

Clémence Nouzé

http://www.w3.org/2001/XMLSchema#string

Cécile Bauche

http://www.w3.org/2001/XMLSchema#string

Laleh Majlessi

http://www.w3.org/2001/XMLSchema#string

Marcela Simsova

http://www.w3.org/2001/XMLSchema#string

Marie-Jésus Rojas

http://www.w3.org/2001/XMLSchema#string

Stewart T Cole

http://www.w3.org/2001/XMLSchema#string

Zdenka Jarvis

http://www.w3.org/2001/XMLSchema#string

P2860

The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)

CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family

Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

Disseminated tuberculosis in interferon gamma gene-disrupted mice

Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis.

Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.

Bordatella pertussis adenylate cyclase: a toxin with multiple talents.

Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids

Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.

P304

2128-2137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.74.4.2128-2137.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Priscille Brodin

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16552042

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

1418924

http://www.w3.org/2001/XMLSchema#string